162 related articles for article (PubMed ID: 18649004)
1. Uroflowmetric assessment of acute effects of sildenafil on the voiding of men with erectile dysfunction and symptomatic benign prostatic hyperplasia.
Guven EO; Balbay MD; Mete K; Serefoglu EC
Int Urol Nephrol; 2009; 41(2):287-92. PubMed ID: 18649004
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial.
McVary KT; Monnig W; Camps JL; Young JM; Tseng LJ; van den Ende G
J Urol; 2007 Mar; 177(3):1071-7. PubMed ID: 17296414
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.
Tuncel A; Nalcacioglu V; Ener K; Aslan Y; Aydin O; Atan A
World J Urol; 2010 Feb; 28(1):17-22. PubMed ID: 19855976
[TBL] [Abstract][Full Text] [Related]
4. Does sildenafil affect uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic enlargement?
Güler C; Tüzel E; Doğantekin E; Kiziltepe G
Urol Int; 2008; 80(2):181-5. PubMed ID: 18362490
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction.
Mulhall JP; Guhring P; Parker M; Hopps C
J Sex Med; 2006 Jul; 3(4):662-667. PubMed ID: 16839322
[TBL] [Abstract][Full Text] [Related]
6. An open, comparative, multicentre clinical study of combined oral therapy with sildenafil and doxazosin GITS for treating Chinese patients with erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Jin Z; Zhang ZC; Liu JH; Lu J; Tang YX; Sun XZ; Song WD; Gao B; Guo YL; Xin ZC
Asian J Androl; 2011 Jul; 13(4):630-5. PubMed ID: 21602833
[TBL] [Abstract][Full Text] [Related]
7. Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment.
Roehrborn CG; Kaminetsky JC; Auerbach SM; Montelongo RM; Elion-Mboussa A; Viktrup L
BJU Int; 2010 Feb; 105(4):502-7. PubMed ID: 19732051
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of sildenafil on uroflowmetric parameters in erectile dysfunction patients with and without lower urinary tract symptoms.
Öztürk MI; Koca O; Sertkaya Z; Keles MO; Kaya C; Karaman MI
J Androl; 2012; 33(6):1165-8. PubMed ID: 22492839
[TBL] [Abstract][Full Text] [Related]
9. [Sildenafil assumption and acute effects on the uroflowmetric parameters].
Masciovecchio S; Del Rosso A; Di Pierro ED; Saldutto P; Paradiso Galatioto G; Vicentini C
Minerva Urol Nefrol; 2013 Sep; 65(3):205-9. PubMed ID: 23872631
[TBL] [Abstract][Full Text] [Related]
10. [The positive effect of sildenafil on LUTS from BPH while treating ED].
Ying J; Yao D; Jiang Y; Ren X; Xu M
Zhonghua Nan Ke Xue; 2004 Sep; 10(9):681-3. PubMed ID: 15497711
[TBL] [Abstract][Full Text] [Related]
11. A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia.
Tamimi NA; Mincik I; Haughie S; Lamb J; Crossland A; Ellis P
BJU Int; 2010 Sep; 106(5):674-80. PubMed ID: 20184577
[TBL] [Abstract][Full Text] [Related]
12. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
[TBL] [Abstract][Full Text] [Related]
13. Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.
Kaplan SA; Gonzalez RR; Te AE
Eur Urol; 2007 Jun; 51(6):1717-23. PubMed ID: 17258855
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil citrate improves erectile function: a randomised double-blind trial with open-label extension.
McVary KT; Kaufman J; Young JM; Tseng LJ
Int J Clin Pract; 2007 Nov; 61(11):1843-9. PubMed ID: 17887993
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
Porst H; Kim ED; Casabé AR; Mirone V; Secrest RJ; Xu L; Sundin DP; Viktrup L;
Eur Urol; 2011 Nov; 60(5):1105-13. PubMed ID: 21871706
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M; Corona G; Salvi M; Vignozzi L; McVary KT; Kaplan SA; Roehrborn CG; Serni S; Mirone V; Carini M; Maggi M
Eur Urol; 2012 May; 61(5):994-1003. PubMed ID: 22405510
[TBL] [Abstract][Full Text] [Related]
17. Daily use of sildenafil 50mg at night effectively ameliorates nocturia in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: an exploratory multicenter, double-blind, randomized, placebo-controlled study.
Ko WJ; Han HH; Ham WS; Lee HW
Aging Male; 2017 Jun; 20(2):81-88. PubMed ID: 28590828
[TBL] [Abstract][Full Text] [Related]
18. Combination of doxazosin and sildenafil exerts an additive relaxing effect compared with each compound alone on human cavernosal and prostatic tissue.
Oger S; Behr-Roussel D; Gorny D; Lecoz O; Lebret T; Denoux Y; Faix A; Leriche A; Wayman C; Alexandre L; Giuliano F
J Sex Med; 2009 Mar; 6(3):836-47. PubMed ID: 19143907
[TBL] [Abstract][Full Text] [Related]
19. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Stief CG; Porst H; Neuser D; Beneke M; Ulbrich E
Eur Urol; 2008 Jun; 53(6):1236-44. PubMed ID: 18281145
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil influences lower urinary tract symptoms.
Sairam K; Kulinskaya E; McNicholas TA; Boustead GB; Hanbury DC
BJU Int; 2002 Dec; 90(9):836-9. PubMed ID: 12460342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
